Connor, Clark & Lunn Investment Management (CC&L)’s Gyre Therapeutics GYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-6,055
| Closed | -$287K | – | 1024 |
|
|
2020
Q4 | $287K | Buy |
6,055
+186
| +3% | +$8.82K | ﹤0.01% | 792 |
|
|
2020
Q3 | $189K | Sell |
5,869
-2,382
| -29% | -$76.7K | ﹤0.01% | 840 |
|
|
2020
Q2 | $363K | Sell |
8,251
-281
| -3% | -$12.4K | ﹤0.01% | 809 |
|
|
2020
Q1 | $280K | Buy |
+8,532
| New | +$280K | ﹤0.01% | 812 |
|
|
2016
Q1 | – | Sell |
-131
| Closed | -$46K | – | 862 |
|
|
2015
Q4 | $46K | Hold |
131
| – | – | ﹤0.01% | 791 |
|
|
2015
Q3 | $68K | Sell |
131
-2
| -2% | -$1.04K | ﹤0.01% | 680 |
|
|
2015
Q2 | $291K | Hold |
133
| – | – | ﹤0.01% | 501 |
|
|
2015
Q1 | $310K | Hold |
133
| – | – | ﹤0.01% | 455 |
|
|
2014
Q4 | $275K | Buy |
133
+13
| +11% | +$26.9K | ﹤0.01% | 475 |
|
|
2014
Q3 | $240K | Buy |
120
+91
| +314% | +$182K | ﹤0.01% | 470 |
|
|
2014
Q2 | $109K | Sell |
29
-59
| -67% | -$222K | ﹤0.01% | 509 |
|
|
2014
Q1 | $362K | Buy |
+88
| New | +$362K | ﹤0.01% | 540 |
|